FMI indicates the human milk oligosaccharides market was valued at USD 339.7 million in 2025, increased to USD 394.5 million in 2026, and is projected to reach USD 1,925.6 million by 2036, reflecting a CAGR of 17.2% during 2026 to 2036. By segment, Fucosylated HMOs lead the Product Type category with a 69.1% share in 2026, while Powder dominates the Form segment with an 84.5% share in 2026.